ClinicalTrials.Veeva

Menu

PECS and Parasternal Block for Breast Surgery (PARAST)

I

Istituti Ospitalieri di Cremona

Status

Completed

Conditions

Mastectomy
Quadrantectomy

Study type

Observational

Funder types

Other

Identifiers

NCT03043755
ANECR_01_17

Details and patient eligibility

About

Propose to evaluate efficacy of association between US guide parasternal block and pectorals nerves block (PECS) as anesthetic option for breast surgery (medial quadrantectomy and simple mastectomy).

All patients undergoing medial quadrantectomy and simple mastectomy in 6 months period will be observed.

All patients receive: US guide parasternal block at T4 and T6 space with 6ml of ropivacaine 0,75% and PECS type 2 block performed with 24ml of ropivacaine 0,75%.

During surgery patients receive light sedation with continuous infusion of propofol

Will be observed:

Additional local anesthetic infiltration from surgeon. Pain at rest and during movement quantified as Numerical Rating Scores (0-10) during the first 12 hours postoperatively.

Eventual side effects such as nausea/vomiting.

Enrollment

32 patients

Sex

Female

Ages

18+ years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • age> 18 years;
  • ASA score I - II - III;
  • undergoing elective medial quadrantectomy breast surgery;
  • undergoing elective mastectomy not reconstruction breast surgery;
  • signed informed consent;

Exclusion criteria

  • chronic therapy with opioids/ antidepressants;
  • urgent/emergent surgery;
  • postoperative transfer to the intensive care unit;
  • known allergy to any drug medication;
  • local skin infection;
  • epilepsy;
  • alcohol or drug abuse;

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2024 Veeva Systems